{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:40:18Z","timestamp":1792741218696,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Young Scientists Fund of the National Natural Science Foundation of China","award":["82302866"],"award-info":[{"award-number":["82302866"]}]},{"name":"Diagnosis and Treatment Technology Promotion and Optimization Management Project of Shanghai Shenkang Hospital Development Center","award":["SHDC12025129"],"award-info":[{"award-number":["SHDC12025129"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08856-x","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:34:45Z","timestamp":1787301285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal interference stimulation rescues dopaminergic neurons in the substantia nigra of MPTP-induced Parkinson\u2019s disease mice via inhibition of lipid peroxidation"],"prefix":"10.1186","volume":"24","author":[{"given":"Lu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengran","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2862-3879","authenticated-orcid":false,"given":"Yulian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"8856_CR1","doi-asserted-by":"publisher","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X.","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"8856_CR2","doi-asserted-by":"publisher","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20(5):385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2.","DOI":"10.1016\/S1474-4422(21)00030-2"},{"issue":"13","key":"8856_CR3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis. Mov Disord. 2014;29(13):1583\u201390. https:\/\/doi.org\/10.1002\/mds.25945.","journal-title":"Mov Disord"},{"issue":"1","key":"8856_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27(1):27\u201342. https:\/\/doi.org\/10.1111\/ene.14108.","journal-title":"Eur J Neurol"},{"key":"8856_CR5","doi-asserted-by":"publisher","unstructured":"Armstrong MJ, Okun MS. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323(6):548\u201360. https:\/\/doi.org\/10.1001\/jama.2019.22360.","DOI":"10.1001\/jama.2019.22360"},{"key":"8856_CR6","doi-asserted-by":"publisher","unstructured":"Chu Y, Hirst WD, Federoff HJ, Harms AS, Stoessl AJ, Kordower JH. Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease. Brain J Neurol. 2024;147(2):444\u201357. https:\/\/doi.org\/10.1093\/brain\/awad388.","DOI":"10.1093\/brain\/awad388"},{"key":"8856_CR7","doi-asserted-by":"publisher","unstructured":"Duan J, Duan W, Pu X, Ma C, Huang H, Xu Z. Lutein inhibits ferroptosis and reduces neuronal cell death induced by Parkinson\u2019s disease through the NRF2-HMOX2 signaling axis. Toxicol Appl Pharmacol. 2025;505:117570. https:\/\/doi.org\/10.1016\/j.taap.2025.117570.","DOI":"10.1016\/j.taap.2025.117570"},{"key":"8856_CR8","doi-asserted-by":"publisher","unstructured":"Gupta S, Khan J, Ghosh S. Molecular mechanism of cognitive impairment associated with Parkinson\u2019s disease: A stroke perspective. Life Sci. 2024;337:122358. https:\/\/doi.org\/10.1016\/j.lfs.2023.122358.","DOI":"10.1016\/j.lfs.2023.122358"},{"key":"8856_CR9","doi-asserted-by":"publisher","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet Lond Engl. 2021;397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X.","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"8856_CR10","doi-asserted-by":"publisher","unstructured":"Lees AJ, Hardy J, Revesz T. Parkinson\u2019s disease. Lancet. 2009;373(9680):2055\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(09)60492-X.","DOI":"10.1016\/S0140-6736(09)60492-X"},{"key":"8856_CR11","doi-asserted-by":"publisher","unstructured":"Gupta S, Jash M, Khan J, Garg S, Roy R, Arshi MU, et al. Discovery of potential Leonurine-based therapeutic lead MJ210 attenuates Parkinson\u2019s disease pathogenesis via NF-\u03baB and MAPK pathways: Mechanistic insights from in vitro and in vivo rotenone models. Eur J Med Chem. 2025;289:117471. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117471.","DOI":"10.1016\/j.ejmech.2025.117471"},{"key":"8856_CR12","doi-asserted-by":"publisher","unstructured":"Sun H, Gan C, Wang L, Ji M, Cao X, Yuan Y, et al. Cortical Disinhibition Drives Freezing of Gait in Parkinson\u2019s Disease and an Exploratory Repetitive Transcranial Magnetic Stimulation Study. Mov Disord Off J Mov Disord Soc. 2023;38(11):2072\u201383. https:\/\/doi.org\/10.1002\/mds.29595.","DOI":"10.1002\/mds.29595"},{"key":"8856_CR13","doi-asserted-by":"publisher","unstructured":"Dietrichs E, Odin P. Algorithms for the treatment of motor problems in Parkinson\u2019s disease. Acta Neurol Scand. 2017;136(5):378\u201385. https:\/\/doi.org\/10.1111\/ane.12733.","DOI":"10.1111\/ane.12733"},{"key":"8856_CR14","doi-asserted-by":"publisher","unstructured":"Tanner CM, Ostrem JL. Parkinson\u2019s Disease. N Engl J Med. 2024;391(5):442\u201352. https:\/\/doi.org\/10.1056\/NEJMra2401857.","DOI":"10.1056\/NEJMra2401857"},{"key":"8856_CR15","doi-asserted-by":"publisher","unstructured":"Hariz M, Blomstedt P. Deep brain stimulation for Parkinson\u2019s disease. J Intern Med. 2022;292(5):764\u201378. https:\/\/doi.org\/10.1111\/joim.13541.","DOI":"10.1111\/joim.13541"},{"key":"8856_CR16","doi-asserted-by":"publisher","unstructured":"Zoon TJC, van Rooijen G, Balm GMFC, Bergfeld IO, Daams JG, Krack P, et al. Apathy Induced by Subthalamic Nucleus Deep Brain Stimulation in Parkinson\u2019s Disease: A Meta-Analysis. Mov Disord Off J Mov Disord Soc. 2021;36(2):317\u201326. https:\/\/doi.org\/10.1002\/mds.28390.","DOI":"10.1002\/mds.28390"},{"key":"8856_CR17","doi-asserted-by":"publisher","unstructured":"Mahlknecht P, Foltynie T, Limousin P, Poewe W. How Does Deep Brain Stimulation Change the Course of Parkinson\u2019s Disease? Mov Disord Off J Mov Disord Soc. 2022;37(8):1581\u201392. https:\/\/doi.org\/10.1002\/mds.29052.","DOI":"10.1002\/mds.29052"},{"key":"8856_CR18","doi-asserted-by":"publisher","unstructured":"Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, et al. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Ann Neurol. 2022;91(3):424\u201335. https:\/\/doi.org\/10.1002\/ana.26302.","DOI":"10.1002\/ana.26302"},{"key":"8856_CR19","doi-asserted-by":"publisher","unstructured":"Reuter S, Deuschl G, Falk D, Mehdorn M, Witt K. Uncoupling of dopaminergic and subthalamic stimulation: Life-threatening DBS withdrawal syndrome. Mov Disord Off J Mov Disord Soc. 2015;30(10):1407\u201313. https:\/\/doi.org\/10.1002\/mds.26324.","DOI":"10.1002\/mds.26324"},{"key":"8856_CR20","doi-asserted-by":"publisher","unstructured":"Flores-Leon M, Outeiro TF. More than meets the eye in Parkinson\u2019s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathol (Berl). 2023;146(3):369\u201385. https:\/\/doi.org\/10.1007\/s00401-023-02601-0.","DOI":"10.1007\/s00401-023-02601-0"},{"key":"8856_CR21","doi-asserted-by":"publisher","unstructured":"Tong B, et al. Targeting dysregulated lipid metabolism for the treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease: Current advancements and future prospects. Neurobiol Dis. 2024;196:106505. https:\/\/doi.org\/10.1016\/j.nbd.2024.106505.","DOI":"10.1016\/j.nbd.2024.106505"},{"key":"8856_CR22","doi-asserted-by":"publisher","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P. Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):73. https:\/\/doi.org\/10.1038\/s41392-023-01353-3.","DOI":"10.1038\/s41392-023-01353-3"},{"key":"8856_CR23","doi-asserted-by":"publisher","unstructured":"Zhao X-R, et al. The interplay between lipid droplets and Parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2025;1871(7):167953. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167953.","DOI":"10.1016\/j.bbadis.2025.167953"},{"key":"8856_CR24","doi-asserted-by":"publisher","unstructured":"Galper J, et al. Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease. Brain J Neurol. 2022;145(10):3472\u201387. https:\/\/doi.org\/10.1093\/brain\/awac176.","DOI":"10.1093\/brain\/awac176"},{"key":"8856_CR25","doi-asserted-by":"publisher","unstructured":"Grossman N, et al. Noninvasive Deep Brain Stimulation via Temporally Interfering Electric Fields. Cell. 2017;169(6):1029\u20131041.e16. https:\/\/doi.org\/10.1016\/j.cell.2017.05.024.","DOI":"10.1016\/j.cell.2017.05.024"},{"key":"8856_CR26","doi-asserted-by":"publisher","unstructured":"Yang C, et al. Transcranial Temporal Interference Stimulation of the Right Globus Pallidus in Parkinson\u2019s Disease. Mov Disord Off J Mov Disord Soc. 2025;40(6):1061\u201369. https:\/\/doi.org\/10.1002\/mds.29967.","DOI":"10.1002\/mds.29967"},{"key":"8856_CR27","doi-asserted-by":"publisher","unstructured":"Li L, et al. Non-invasive Modulation of Deep Brain Nuclei by Temporal Interference Stimulation. Neurosci Bull. 2025;41(5):853\u201365. https:\/\/doi.org\/10.1007\/s12264-025-01359-7.","DOI":"10.1007\/s12264-025-01359-7"},{"key":"8856_CR28","doi-asserted-by":"publisher","unstructured":"Demchenko I, et al. Human applications of transcranial temporal interference stimulation: A systematic review. Brain Stimul Basic Transl Clin Res Neuromodulation. 2025;18(6):2054\u201366. https:\/\/doi.org\/10.1016\/j.brs.2025.10.023.","DOI":"10.1016\/j.brs.2025.10.023"},{"key":"8856_CR29","doi-asserted-by":"publisher","unstructured":"Wang F, Jiang M, Deng D, Tu Y. Temporal interference stimulation for human brain: Opportunities and challenges. The Innovation. 2025;6(4):100803. https:\/\/doi.org\/10.1016\/j.xinn.2025.100803.","DOI":"10.1016\/j.xinn.2025.100803"},{"key":"8856_CR30","doi-asserted-by":"publisher","unstructured":"Zhou H, et al. Transcranial temporal interference stimulation for treating bipolar disorder with depressive episodes: a feasibility Study. Mol Psychiatry. 2025;30(12):6099\u20136106. https:\/\/doi.org\/10.1038\/s41380-025-03292-7.","DOI":"10.1038\/s41380-025-03292-7"},{"key":"8856_CR31","doi-asserted-by":"publisher","unstructured":"Chinta SJ, et al. Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson\u2019s Disease. Cell Rep. 2018;22(4):930\u201340. https:\/\/doi.org\/10.1016\/j.celrep.2017.12.092.","DOI":"10.1016\/j.celrep.2017.12.092"},{"key":"8856_CR32","doi-asserted-by":"publisher","unstructured":"Bai X, et al. Deficiency of miR-29b2\/c leads to accelerated aging and neuroprotection in MPTP-induced Parkinson\u2019s disease mice. Aging. 2021;13(18):22390\u201322411. https:\/\/doi.org\/10.18632\/aging.203545.","DOI":"10.18632\/aging.203545"},{"key":"8856_CR33","doi-asserted-by":"publisher","unstructured":"Zhang X, et al. Pyroptosis-mediator GSDMD promotes Parkinson\u2019s disease pathology via microglial activation and dopaminergic neuronal death. Brain Behav Immun. 2024;119:129\u201345. https:\/\/doi.org\/10.1016\/j.bbi.2024.03.038.","DOI":"10.1016\/j.bbi.2024.03.038"},{"key":"8856_CR34","doi-asserted-by":"publisher","unstructured":"Mitsumoto Y, Watanabe A, Mori A, Koga N. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL\/6 mice. Biochem Biophys Res Commun. 1998;248(3):660\u201363. https:\/\/doi.org\/10.1006\/bbrc.1998.8986.","DOI":"10.1006\/bbrc.1998.8986"},{"key":"8856_CR35","doi-asserted-by":"publisher","unstructured":"Taketomi Y, et al. Lipid-orchestrated paracrine circuit coordinates mast cell maturation and anaphylaxis through functional interaction with fibroblasts. Immunity. 2024;57(8):1828\u20131847.e11. https:\/\/doi.org\/10.1016\/j.immuni.2024.06.012.","DOI":"10.1016\/j.immuni.2024.06.012"},{"key":"8856_CR36","doi-asserted-by":"publisher","unstructured":"Ray U, et al. Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization. J Exp Clin Cancer Res CR. 2021;40:182. https:\/\/doi.org\/10.1186\/s13046-021-01985-9.","DOI":"10.1186\/s13046-021-01985-9"},{"key":"8856_CR37","doi-asserted-by":"publisher","unstructured":"Zhou X, et al. ACSL4 promotes microglia-mediated neuroinflammation by regulating lipid metabolism and VGLL4 expression. Brain Behav Immun. 2023;109:331\u201343. https:\/\/doi.org\/10.1016\/j.bbi.2023.02.012.","DOI":"10.1016\/j.bbi.2023.02.012"},{"key":"8856_CR38","doi-asserted-by":"publisher","unstructured":"Doll S, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239.","DOI":"10.1038\/nchembio.2239"},{"key":"8856_CR39","doi-asserted-by":"publisher","unstructured":"Zhang J, et al. Scutellaria baicalensis Extracts Restrict Intestinal Epithelial Cell Ferroptosis by Regulating Lipid Peroxidation and GPX4\/ACSL4 in Colitis. Phytomedicine. 2025;141:156708. https:\/\/doi.org\/10.1016\/j.phymed.2025.156708.","DOI":"10.1016\/j.phymed.2025.156708"},{"key":"8856_CR40","doi-asserted-by":"publisher","unstructured":"Richards CD, Shiroyama T, Kitai ST. Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat. Neuroscience. 1997;80(2):545\u201357. https:\/\/doi.org\/10.1016\/s0306-4522(97)00093-6.","DOI":"10.1016\/s0306-4522(97)00093-6"},{"key":"8856_CR41","doi-asserted-by":"publisher","unstructured":"Millard SJ, et al. Cognitive representations of intracranial self-stimulation of midbrain dopamine neurons depend on stimulation frequency. Nat Neurosci. 2024;27(7):1253\u201359. https:\/\/doi.org\/10.1038\/s41593-024-01643-1.","DOI":"10.1038\/s41593-024-01643-1"},{"key":"8856_CR42","doi-asserted-by":"publisher","first-page":"8215017","DOI":"10.1155\/2019\/8215017","volume":"2019","author":"E Palasz","year":"2019","unstructured":"Palasz E, Niewiadomski W, Gasiorowska A, Mietelska-Porowska A, Niewiadomska G. Neuroplasticity and Neuroprotective Effect of Treadmill Training in the Chronic Mouse Model of Parkinson\u2019s Disease. Neural Plast. 2019;2019:8215017. https:\/\/doi.org\/10.1155\/2019\/8215017.","journal-title":"Neural Plast"},{"key":"8856_CR43","doi-asserted-by":"publisher","unstructured":"Qi Y, et al. Whether the Subacute MPTP-Treated Mouse is as Suitable as a Classic Model of Parkinsonism. Neuromolecular Med. 2023;25(3):360\u201374. https:\/\/doi.org\/10.1007\/s12017-023-08740-7.","DOI":"10.1007\/s12017-023-08740-7"},{"issue":"4","key":"8856_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3233\/JAD-2010-101348","volume":"22","author":"A Mart\u00ednez-Garc\u00eda","year":"2010","unstructured":"Mart\u00ednez-Garc\u00eda A, et al. PLA2G3, a gene involved in oxidative stress induced death, is associated with Alzheimer\u2019s disease. J Alzheimers Dis JAD. 2010;22(4):1181\u201387. https:\/\/doi.org\/10.3233\/JAD-2010-101348.","journal-title":"J Alzheimers Dis JAD"},{"key":"8856_CR45","doi-asserted-by":"publisher","unstructured":"Kumar A, Behl T, Jamwal S, Kaur I, Sood A, Kumar P. Exploring the molecular approach of COX and LOX in Alzheimer\u2019s and Parkinson\u2019s disorder. Mol Biol Rep. 2020;47(12):9895\u20139912. https:\/\/doi.org\/10.1007\/s11033-020-06033-x.","DOI":"10.1007\/s11033-020-06033-x"},{"key":"8856_CR46","doi-asserted-by":"publisher","unstructured":"Maiti AK. The genetics of phospholipase A2 induced redox signaling in neuroinflammation and neuronal diseases. In: Phospholipases in Physiology and Pathology. Elsevier; 2023. p. 307\u201327. https:\/\/doi.org\/10.1016\/B978-0-323-95698-7.00017-6.","DOI":"10.1016\/B978-0-323-95698-7.00017-6"},{"key":"8856_CR47","doi-asserted-by":"publisher","unstructured":"Jagusch H, Werner M, Werz O, Pohnert G. 15-Hydroperoxy-PGE2: Intermediate in Mammalian and Algal Prostaglandin Biosynthesis. Angew Chem Int Ed Engl. 2019;58(49):17641\u201345. https:\/\/doi.org\/10.1002\/anie.201910461.","DOI":"10.1002\/anie.201910461"},{"key":"8856_CR48","doi-asserted-by":"publisher","unstructured":"Zhang Y, Liu Y, Sun J, Zhang W, Guo Z, Ma Q. Arachidonic acid metabolism in health and disease. MedComm. 2023;4(5):e363. https:\/\/doi.org\/10.1002\/mco2.363.","DOI":"10.1002\/mco2.363"},{"key":"8856_CR49","doi-asserted-by":"publisher","unstructured":"Wang B, Zhao Z, Guo R-N, Wu X, Qian Z. Enhanced focality and intensity in deep brain targeting: In silico study on multi-channel temporal interference stimulation for Parkinson\u2019s disease. Neuroscience. 2025;582:72\u201381. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.07.028.","DOI":"10.1016\/j.neuroscience.2025.07.028"},{"key":"8856_CR50","doi-asserted-by":"publisher","unstructured":"Liu R, et al. Temporal interference stimulation targets deep primate brain. NeuroImage. 2024;291:120581. https:\/\/doi.org\/10.1016\/j.neuroimage.2024.120581.","DOI":"10.1016\/j.neuroimage.2024.120581"},{"key":"8856_CR51","doi-asserted-by":"publisher","unstructured":"Demchenko I, et al. Human applications of transcranial temporal interference stimulation: A systematic review. Brain Stimulat. 2025;18(6):2054\u201366. https:\/\/doi.org\/10.1016\/j.brs.2025.10.023.","DOI":"10.1016\/j.brs.2025.10.023"},{"key":"8856_CR52","doi-asserted-by":"publisher","unstructured":"Yang C, et al. Transcranial temporal interference stimulation targeting the subthalamic region for motor symptoms in Parkinson\u2019s disease: a pilot, randomised, double-blind, sham-controlled crossover study. eBioMedicine. 2026;127:106245. https:\/\/doi.org\/10.1016\/j.ebiom.2026.106245.","DOI":"10.1016\/j.ebiom.2026.106245"},{"key":"8856_CR53","unstructured":"Temporal interference stimulation: A new paradigm for non-invasive deep brain stimulation\u2014mechanistic insights, clinical advances, and future directions. Transl Psychiatry. 2026. Accessed Jul 28, 2026. [Online]. https:\/\/www.nature.com\/articles\/s41398-026-04263-4."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08856-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08856-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08856-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:17:07Z","timestamp":1792739827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08856-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8856"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08856-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"16 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were conducted in accordance with the standards established by the Animal Protection and Use Committee of Huashan Hospital, Fudan University (Approval No.: 202407016\u00a0S), and were performed by trained personnel.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no known competing financial interests or personal relationships that could have appeared to influence the work described in this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1336"}}